Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review

References

• Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727‐733. doi:10.1056/NEJMoa2001017
   Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497‐506. doi:10.1016/S0140-6736(20)30183-5
   Web of Science ®Google Scholar
• Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect. 2020;9(1):747‐756. doi:10.1080/22221751.2020.1745095
   Web of Science ®Google Scholar
• WHO situation report-111. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200510covid-19-sitrep-111.pdf?sfvrsn=1896976f_2. Accessed 510, 2020.
   Google Scholar
• World Health Organization Press Conference. The World Health Organization (WHO) has officially named the disease caused by the Novel Coronavirus as COVID-19. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 723, 2020.
   Google Scholar
• Guo G, Ye L, Pan K, et al. New insights of emerging SARS-CoV-2: epidemiology, etiology, clinical features, clinical treatment, and prevention. Front Cell Dev Biol. 2020;8:410. doi:10.3389/fcell.2020.0041032574318
   PubMed Web of Science ®Google Scholar
• Yu IT, Li Y, Wong TW, et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med. 2004;350(17):1731–1739. doi:10.1056/NEJMoa03286715102999
   PubMed Web of Science ®Google Scholar
• Yang R, Gui X, Xiong Y. Patients with respiratory symptoms are at greater risk of COVID-19 transmission. Respir Med. 2020;165:105935. doi:10.1016/j.rmed.2020.10593532308203
   PubMed Web of Science ®Google Scholar
• Han Y, Yang H. The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective. J Med Virol. 2020;92(6):639–644. doi:10.1002/jmv.2574932141619
   PubMed Web of Science ®Google Scholar
• Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3(1):237‐261. doi:10.1146/annurev-virology-110615-042301
   Web of Science ®Google Scholar
• de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523‐534. doi:10.1038/nrmicro.2016.81
   PubMed Web of Science ®Google Scholar
• Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181‐192. doi:10.1038/s41579-018-0118-9
   Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270‐273. doi:10.1038/s41586-020-2012-7
   Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565‐574. doi:10.1016/S0140-6736(20)30251-8
   Web of Science ®Google Scholar
• Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020;79:104212. doi:10.1016/j.meegid.2020.10421232004758
   PubMed Web of Science ®Google Scholar
• Kang S, Peng W, Zhu Y, et al. Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment [published online ahead of print, 2020 Mar 29]. Int J Antimicrob Agents. 2020;55:105950. doi:10.1016/j.ijantimicag.2020.10595032234465
   PubMed Web of Science ®Google Scholar
• Gao Y, Yan L, Huang Y, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus [published online ahead of print, 2020 Apr 10]. Science. 2020:eabb7498 10.1126/science.abb7498.
   Web of Science ®Google Scholar
• Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the Novel Coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325‐328. doi:10.1016/j.chom.2020.02.001
   Web of Science ®Google Scholar
• Yang P, Wang X. COVID-19: a new challenge for human beings. Cell Mol Immunol. 2020;17(5):555‐557. doi:10.1038/s41423-020-0407-x
   Web of Science ®Google Scholar
• Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2 [published online ahead of print, 2020 Apr 16]. Gene Rep. 2020;19:100682. doi:10.1016/j.genrep.2020.100682
   PubMed Web of Science ®Google Scholar
• Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: their roles in pathogenesis [published online ahead of print, 2020 Mar 31]. J Microbiol Immunol Infect. 2020. doi:10.1016/j.jmii.2020.03.022
   Google Scholar
• Kirchdoerfer RN, Cottrell CA, Wang N, et al. Pre-fusion structure of a human coronavirus spike protein. Nature. 2016;531(7592):118‐121. doi:10.1038/nature17200
   Web of Science ®Google Scholar
• Ou X, Liu Y, Lei X, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11(1):1620. doi:10.1038/s41467-020-15562-932221306
   PubMed Web of Science ®Google Scholar
• Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281‐292.e6. doi:10.1016/j.cell.2020.02.058
   Web of Science ®Google Scholar
• Yuan Y, Cao D, Zhang Y, et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun. 2017;8:15092. doi:10.1038/ncomms1509228393837
   PubMed Web of Science ®Google Scholar
• Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444‐1448. doi:10.1126/science.abb2762
   Web of Science ®Google Scholar
• Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260‐1263. doi:10.1126/science.abb2507
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang Y, Wu L, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2 [published online ahead of print, 2020 Apr 7]. Cell. 2020;S00928674(20):30338X. doi:10.1016/j.cell.2020.03.045
   Web of Science ®Google Scholar
• de Haan CA, Kuo L, Masters PS, Vennema H, Rottier PJ. Coronavirus particle assembly: primary structure requirements of the membrane protein. J Virol. 1998;72(8):6838‐6850. doi:10.1128/JVI.72.8.6838-6850.1998
   Web of Science ®Google Scholar
• Che XY, Qiu LW, Liao ZY, et al. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. J Infect Dis. 2005;191(12):2033‐2037. doi:10.1086/430355
   Web of Science ®Google Scholar
• To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565‐574. doi:10.1016/S1473-3099(20)30196-1
   Web of Science ®Google Scholar
• Kumar S, Maurya VK, Prasad AK, Bhatt MLB, Saxena SK. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). Virusdisease. 2020;31(1):13‐21. doi:10.1007/s13337-020-00571-5
   Google Scholar
• Petherick A. Developing antibody tests for SARS-CoV-2. Lancet. 2020;395(10230):1101‐1102. doi:10.1016/S0140-6736(20)30788-1
   Web of Science ®Google Scholar
• Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457‐460. doi:10.1007/s11427-020-1637-5
   Web of Science ®Google Scholar
• Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor [published online ahead of print, 2020 Mar 30]. Nature. 2020. doi:10.1038/s41586-020-2180-5
   Web of Science ®Google Scholar
• Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. WHO; [ Cited 3 19, 2020]. Available from: https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117. Accessed 723, 2020.
   Google Scholar
• Evaluating and testing persons for Coronavirus Disease 2019 (COVID-19). Available from: www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html. Accessed 419, 2020.
   Google Scholar
• Cheng MP, Papenburg J, Desjardins M, et al. Diagnostic testing for severe acute respiratory syndrome-related Coronavirus-2: a narrative review [published online ahead of print, 2020 Apr 13]. Ann Intern Med. 2020:M201301 10.7326/M20-1301.
   Web of Science ®Google Scholar
• Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514‐523. doi:10.1016/S0140-6736(20)30154-9
   Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [published online ahead of print, 2020 Feb 7]. JAMA. 2020;323(11):1061‐1069. doi:10.1001/jama.2020.1585
   Web of Science ®Google Scholar
• WHO Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans. Available from: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/technical-guidance/laboratory-guidance. Accessed 4 17, 2020.
   Google Scholar
• Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) [published online ahead of print, 2020 Mar 16]. Clin Chem Lab Med. 2020 10.1515/cclm-2020-0285
   Web of Science ®Google Scholar
• Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19 [published online ahead of print, 2020 Mar 19]. Lancet Infect Dis. 2020;S14733099(20):230232. doi:10.1016/S1473-3099(20)30232-2
   Web of Science ®Google Scholar
• Vermeiren C, Marchand-Senécal X, Sheldrake E, et al. Comparison of Copan Eswab and FLOQswab for COVID-19 PCR diagnosis: working around a supply shortage [published online ahead of print, 2020 Apr 15]. J Clin Microbiol. 2020:JCM.00669–20. doi:10.1128/JCM.00669-20.
   Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA. Stockholm: ECDC; [ Cited 4 1, 2020]. Available from: https://www.ecdc.europa.eu/en/novelcoronavirus/laboratory-support. Accessed on 418, 2020.
   Google Scholar
• Yang T, Wang YC, Shen CF, Cheng CM. Point-of-Care RNA-based diagnostic device for COVID-19. Diagnostics. 2020;10(3:165. doi:10.3390/diagnostics10030165.
   Web of Science ®Google Scholar
• Mahmood S, Hasan K, Colder Carras M, Labrique A. Global preparedness against COVID-19: we must leverage the power of digital health. JMIR Public Health Surveill. 2020;6(2:e18980. doi:10.2196/18980.32297868
   PubMedGoogle Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045. doi:10.2807/1560-7917.ES.2020.25.3.2000045
   PubMedGoogle Scholar
• Chu DKW, Pan Y, Cheng SMS, et al. Molecular diagnosis of a Novel Coronavirus (2019-nCoV) causing an outbreak of Pneumonia. Clin Chem. 2020;66(4):549‐555. doi:10.1093/clinchem/hvaa029
   Web of Science ®Google Scholar
• Kim H, Hong H, Yoon SH. Diagnostic Performance of CT and reverse transcriptase-polymerase chain reaction for Coronavirus Disease 2019: a meta-analysis [published online ahead of print, 2020 Apr 17]. Radiology. 2020;201343. doi:10.1148/radiol.202020134332301646
   PubMed Web of Science ®Google Scholar
• Xiao AT, Tong YX, Zhang S. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence. J Med Virol. 2020. doi:10.1002/jmv.25855
   Web of Science ®Google Scholar
• Wang X, Yao H, Xu X, et al. Limits of detection of six approved RT-PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2) [published online ahead of print, 2020 Apr 13]. Clin Chem. 2020:hvaa099. doi:10.1093/clinchem/hvaa099.
   Web of Science ®Google Scholar
• Li Y, Yao L, Li J, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19 [published online ahead of print, 2020 Mar 26]. J Med Virol. 2020. doi:10.1002/jmv.25786
   Web of Science ®Google Scholar
• Azzi L, Carcano G, Gianfagna F, et al. Saliva is a reliable tool to detect SARS-CoV-2 [published online ahead of print, 2020 Apr 14]. J Infect. 2020;S01634453(20):30213–30219. doi:10.1016/j.jinf.2020.04.005
   Web of Science ®Google Scholar
• Guo WL, Jiang Q, Ye F, et al. Effect of throat washings on detection of 2019 novel coronavirus [published online ahead of print, 2020 Apr 9]. Clin Infect Dis. 2020:ciaa416. doi:10.1093/cid/ciaa416.32271374
   PubMed Web of Science ®Google Scholar
• Baek YH, Um J, Antigua KJC, et al. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2 [published online ahead of print, 2020 Apr 20]. Emerg Microbes Infect. 2020:1‐31. doi:10.1080/22221751.2020.1756698.
   Web of Science ®Google Scholar
• Huang WE, Lim B, Hsu CC, et al. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2 [published online ahead of print, 2020 Apr 25]. Microb Biotechnol. 2020. doi:10.1111/1751-7915.13586
   Web of Science ®Google Scholar
• Castro R, Luz PM, Wakimoto MD, Veloso VG, Grinsztejn B, Perazzo H. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil [published online ahead of print, 2020 Apr 18]. Braz J Infect Dis. 2020;S14138670(20):530029. doi:10.1016/j.bjid.2020.04.003
   Web of Science ®Google Scholar
• SARS-COV-2 DIAGNOSTIC PIPELINE. Available from: https://www.finddx.org/covid-19/pipeline/?section=show-all#diag_tab. Accessed on 48, 2020.
   Google Scholar
• Report of the WHO-china joint mission on Coronavirus Disease 2019 (COVID-19). Geneva, Switzerland:WHO;2020 Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed 418, 2020.
   Google Scholar
• Zhang L, Zhang F, Yu W, et al. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol. 2006;78(1):1‐8. doi:10.1002/jmv.20499
   Web of Science ®Google Scholar
• Liu L, Wei Q, Lin Q, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019;4(4):e123158. doi:10.1172/jci.insight.123158
   PubMed Web of Science ®Google Scholar
• Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 [published online ahead of print, 2020 Mar 28]. Clin Infect Dis. 2020:ciaa344. doi:10.1093/cid/ciaa344.32221519
   PubMed Web of Science ®Google Scholar
• Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19 [published online ahead of print, 2020 Apr 29]. Nat Med. 2020. doi:10.1038/s41591-020-0897-1
   Web of Science ®Google Scholar
• Vashist SK. In vitro diagnostic assays for COVID-19: recent advances and emerging trends. Diagnostics. 2020;10(4:E202. doi:10.3390/diagnostics10040202.32260471
   PubMed Web of Science ®Google Scholar
• Padoan A, Cosma C, Sciacovelli L, Faggian D, Plebani M. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics [published online ahead of print, 2020 Apr 16]. Clin Chem Lab Med. 2020. doi:10.1515/cclm-2020-0443
   Web of Science ®Google Scholar
• Li Z, Yi Y, Luo X, et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis [published online ahead of print, 2020 Feb 27]. J Med Virol. 2020. doi:10.1002/jmv.25727
   Web of Science ®Google Scholar
• Cassaniti I, Novazzi F, Giardina F, et al. Performance of VivaDiag COVID-19 IgM/IgG rapid test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department [published online ahead of print, 2020 Mar 30]. J Med Virol. 2020. doi:10.1002/jmv.25800
   Web of Science ®Google Scholar
• Sardu C, D’Onofrio N, Balestrieri ML, et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? Diabetes Care. 2020;43(7):1408–1415. doi:10.2337/dc20-072332430456
   PubMed Web of Science ®Google Scholar
• Marfella R, Paolisso P, Sardu C, et al. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diab Metab. 2020;S12623636(20):30082–30083. doi:10.1016/j.diabet.2020.05.005
   Web of Science ®Google Scholar
• Sagnelli C, Gentile V, Tirri R, et al. Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient. J Infect. 2020;S01634453(20):30322–30324. doi:10.1016/j.jinf.2020.05.043
   Web of Science ®Google Scholar